![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/8/86/Metazocine.svg/640px-Metazocine.svg.png&w=640&q=50)
Metazocine
Opioid analgesic / From Wikipedia, the free encyclopedia
Metazocine is an opioid analgesic related to pentazocine. While metazocine has significant analgesic effects,[2] mediated through a mixed agonist–antagonist action[3] at the mu opioid receptor,[4] its clinical use is limited by dysphoric and hallucinogenic effects which are most likely caused by activity at kappa opioid receptors (where it is a high-efficacy agonist)[5] and/or sigma receptors.[6][7]
![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.020.998 ![]() |
Chemical and physical data | |
Formula | C15H21NO |
Molar mass | 231.339 g·mol−1 |
3D model (JSmol) | |
| |
|
Metazocine is in Schedule II of the Controlled Substances Act 1970 of the United States as a Narcotic with ACSCN 9240 with a 19 gram aggregate manufacturing quota as of 2014. The free base conversion ratio for salts includes 0.81 for the hydrochloride and 0.74 for the hydrobromide.[8] It is listed under the Single Convention for the Control of Narcotic Substances 1961 and is controlled in most countries in the same fashion as is morphine.